This research study is creating a way to collect and store specimens and information from participants who may be at an increased risk of developing cancer, or…

Cancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more

~Estimated

~$10 – $1,125

Dana-Farber Cancer InstituteNCT05463796

Phase 2

A Phase 2 Study of Intralesional RP2 as Immunoprevention for High-Risk Oral Precancerous Disease (INTERCEPT)

The goal of this study is to understand the safety, tolerability, and potential efficacy of an injected immune therapy called RP2 to treat oral precancer condi…

High-Risk Oral Precancerous Disease

~Estimated

~$10 – $7,500

Glenn J. HannaNCT06623110